Published in AIDS Weekly, October 1st, 2007
"This approach often becomes cumbersome to patients, involving multiple drugs administered on varying schedules. We investigated the pharmacolkinetics, efficacy, and tolerability of a once-daily regimen of fosamprenavir, tenofovir, emtricitabine and ritonavir in HIV-infected treatment-naive subjects," wrote D.A. Parks and colleagues.
The researchers concluded: "No clinically significant interaction between the drugs was noted, and the regimen showed good efficacy and tolerability over...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.